Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children

NCT03859700 is registered in ClinicalTrials.gov with DBV Technologies as lead sponsor.

NCT NCT03859700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03859700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children
Lead sponsor
DBV Technologies
Phase
Phase 3
Overall status
Completed
Start date
December 6, 2018
Completion date
May 13, 2025
Enrollment
304 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

peanut allergy